Fact Sheet August 21, 2025 | [E] | [E] | [E] | Segment | Revenue | - FY'25 | View | FY'23 | FY'24 | FY'25 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ...

DAW N Z E R AT M F DA A P P R OVA L N a s d a q : I O N S August 2025 Forward-Looking Statements This presentation includes forward-looking statements regarding the therapeutic and commercial potential of DAWNZERA (donidalorsen), Ionis' technologies, and Ionis' other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to cer ...

Review of Financial Results Third Quarter Fiscal 2025 【0367 Forward-Looking Statements All statements in this presentation that are not historical facts should be considered as "Forward-Looking Statements" within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, ncertainties and other factors that may cause actual results, performance or achievements of the Company to be materially different from any future r ...

Financial Performance - LSI Industries' Q4FY25 sales increased by 20% year-over-year, reaching $155.1 million compared to $129.0 million in Q4FY24 [14, 22] - Organic sales grew by 11%, driven by improved demand across key vertical markets [12, 14, 21] - Adjusted EBITDA increased by 21% compared to the prior year, leading to a margin improvement of 250 basis points from Q3FY25 [15, 21] - Net income adjusted reached $10.6 million in Q4FY25, compared to $8.3 million in Q4FY24 [23] - For the full year FY25, total net sales reached $573.4 million, compared to $469.6 million in FY24 [22] Segment Performance - Display Solutions sales increased by 29%, with 10% organic sales growth, driven by Refueling / C-Store (+23%) and Grocery (+31%) [29] - Lighting revenues increased by 12% due to improved project order rates, with a 20% growth in backlog exiting the year [17] Balance Sheet and Cash Flow - The company generated free cash flow of $8.5 million in Q4FY25, with a trailing twelve-month (TTM) free cash flow of $34.7 million [50, 52] - Net debt stood at $45.1 million through Q4FY25, with a net leverage ratio of 0.8x [50, 55, 56]

Financial Performance - BBVA Argentina's Net Income decreased, reflected in declines in ROA and ROE [3] - Net Interest Income improved due to commercial efforts, with Financial Margin at AR$ 591.8 billion, up 11.4% YoY [5] - Operating Expenses remained stable, leading to an Efficiency Ratio of 56.5% [5] - Loan Loss Allowances increased to AR$ 144.5 billion due to loan book growth [5] Loan Portfolio & Asset Quality - Private Loans increased by 16.3% QoQ, outpacing the 6% inflation [10] - The bank experienced real growth in its loan portfolio due to higher commercial activity [7] Deposits & Capital - Private Deposits increased, leading to a higher market share [21] - Total Liquid Assets to Total Deposits ratio is 11.5% [25] - Capital ratio declined due to credit portfolio growth and dividend distribution [24] Digital Transformation - New Retail Customer Acquisition increased, with a 100 bps increase in digital acquisition compared to 2Q24 [29] - Digital & Mobile Active Clients grew by 7% YoY [29]

Disclaimer and Forward-Looking Statement Statements relating to our future plans, projections, events or prospects are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include all statements that are not historical facts and can be identified by terms such as "believes," "continue," "could," "potential," "remain," "will," "would" or similar expressions and the negatives of those terms. Forward-looking statements involve known ...

Financial Performance - Full year sales increased by 15.5% year-over-year to $340.7 million[8] - Organic sales increased by 1.0% year-over-year[8] - EBITDA was $19.0 million, including currency translation loss, stock-based compensation, and other items[8] - Operating Cash Flow reached $24.0 million[8] - Free cash flow amounted to $8.8 million[8] - The company's six-month backlog was $150.5 million, showing sequential growth[8] - Net debt to EBITDA leverage ratio increased from 0.2x in FY24 to 0.8x in FY25, primarily due to the acquisition of Kobelt[45, 46] Market and Strategic Highlights - Defense backlog increased by 45% year-over-year as a percentage of total major geographies backlog[11] - Defense accounts for approximately 15% of the total backlog[11] - Industrial sales increased by 82.0% year-over-year[23] - Industrial sales excluding Katsa and Kobelt increased 13.1% year-over-year[23]

Financial Performance - Q4 Fiscal 2025 - Consolidated revenue decreased to $138.5 million, a 12.0% decrease compared to Q4 Fiscal 2024[15] - Adjusted EPS was ($0.56), a 155% decrease compared to the prior year[15] - Adjusted EBITDA was ($4.1) million, a 169% decrease compared to the prior year[15] - REPREVE® Fiber sales accounted for 30% of net sales, a decrease of 400 bps[15] - Gross loss was ($1.1) million, a 110.5% decrease compared to the prior year, with a gross margin of (0.8)%, a decrease of 770 bps[29] Segment Performance - Q4 Fiscal 2025 - Americas net sales decreased by 6.6% to $85.0 million, with a gross loss of ($5.3) million and a gross margin of (6.3)%[33] - Brazil net sales decreased by 10.6% to $28.8 million, with a gross profit of $1.3 million and a gross margin of 4.6%[36] - Asia net sales decreased by 27.7% to $24.7 million, with a gross profit of $2.9 million and a gross margin of 11.7%[40] Capital Structure and Outlook - The company expects Q1 FY26 net sales and Adjusted EBITDA to improve sequentially from Q4 FY25[48] - Recent asset sale reduced debt principal by $43 million and is expected to drive future annual savings of $3 million for interest and $20 million for manufacturing costs[44]

Company Overview - Nordson's revenue in 2024 was $2.7 billion, with an EBITDA margin of 32%[5] - The company has a diversified geographic footprint, with 44% of sales in the Americas, 27% in Europe, and 29% in Asia Pacific[10] - Nordson has a diversified product portfolio with over 2,100 global patents held[7] Sales and Revenue - Systems account for 42% of FY2024 sales, while parts and consumables make up 58%[9] - Industrial Precision Solutions (IPS) generated $1.4 million in fiscal 2024 revenue with 37% EBITDA[24] - Medical Fluid Solutions (MFS) generated $696 million in fiscal 2024 revenue with 37% EBITDA[34] - Advanced Technology Solutions (ATS) generated $596 million in fiscal 2024 revenue with 22% EBITDA[39] Financial Performance and Targets - The company targets average annual revenue growth of 6-8% and adjusted EPS growth of 10-12% from 2025-2029[51] - Nordson anticipates generating approximately $4.1 billion in operating cash flows through 2029[65] - The company reported sales of $742 million for 3Q 2025, a 12% increase, with EBITDA of $239 million, up 15%[73] - 3Q25 free cash flow was $226 million, representing a conversion rate of 180% of net income[79]

Acquisition Overview - McCormick will acquire an additional 25% ownership in McCormick de Mexico for $750 million, increasing its total ownership to 75%[11, 11] - The acquisition is expected to close early in 2026[13, 38] - The company expects the acquisition to be accretive to earnings in year 1, inclusive of eliminating 25% of McCormick de Mexico's Net Income[13] Financial Impact - McCormick de Mexico has approximately $810 million in net sales and $180 million in EBITDA, with $16 million in annual management fees[13, 40] - The transaction value implies a multiple of 12x 2025 EBITDA and annual management fees[38] - The company anticipates adjusted operating margin accretion, primarily in the Consumer segment, in year 1[13, 38] - The company expects mid-single digit sales growth, aligned with long-term objectives[38] - The company anticipates approximately $10 million - $12 million in transaction costs[38] Strategic Rationale - The acquisition advances flavor leadership in Mexico, an attractive and growing market[12, 48] - The acquisition expands the global condiment platform and capitalizes on the growing demand for flavor[12] - The acquisition reinforces mayonnaise as a core component of the condiments and sauces portfolio[12, 48] - The acquisition provides a strategic platform for broader growth across Latin America[12, 23, 48]